119 related articles for article (PubMed ID: 3756887)
21. A phase I clinical trial of sequentially administered doxorubicin and topotecan in refractory solid tumors.
Seiden MV; Ng SW; Supko JG; Ryan DP; Clark JW; Lynch T; Huang KC; Kwiatkowski D; Skarin A; Eder JP
Clin Cancer Res; 2002 Mar; 8(3):691-7. PubMed ID: 11895897
[TBL] [Abstract][Full Text] [Related]
22. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
Berruti A; Terzolo M; Pia A; Angeli A; Dogliotti L
Cancer; 1998 Nov; 83(10):2194-200. PubMed ID: 9827725
[TBL] [Abstract][Full Text] [Related]
23. AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma.
Gill PS; Mitsuyasu RT; Montgomery T; Huang J; Cabriales S; Testa M; Espina BM; Levine AM; Miles SA
Cancer J Sci Am; 1997; 3(5):278-83. PubMed ID: 9327151
[TBL] [Abstract][Full Text] [Related]
24. Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.
de Gast GC; Klümpen HJ; Vyth-Dreese FA; Kersten MJ; Verra NC; Sein J; Batchelor D; Nooijen WJ; Schornagel JH
Clin Cancer Res; 2000 Apr; 6(4):1267-72. PubMed ID: 10778950
[TBL] [Abstract][Full Text] [Related]
25. Rationale for and conduct of a phase I clinical trial with interferon alfa-2b plus doxorubicin.
Von Hoff DD; Sarosy G; Brown TD; Kuhn JG; Kisner DL
Semin Oncol; 1986 Sep; 13(3 Suppl 2):72-7. PubMed ID: 3764442
[TBL] [Abstract][Full Text] [Related]
26. Phase II trial of recombinant beta interferon in advanced colorectal cancer.
Lillis PK; Brown TD; Beougher K; Koeller J; Marcus SG; Von Hoff DD
Cancer Treat Rep; 1987 Oct; 71(10):965-7. PubMed ID: 3308080
[TBL] [Abstract][Full Text] [Related]
27. Phase I study of recombinant methionyl human consensus interferon (r-metHuIFN-Con1).
Neidhart JA; Schmidt S; Rosenblum M; Raber MN; Quesada JR; Alton NK; Downing M
J Biol Response Mod; 1988 Jun; 7(3):240-8. PubMed ID: 3392552
[TBL] [Abstract][Full Text] [Related]
28. Phase I study of escalating dose mitoxantrone in combination with alpha-2-interferon in patients with advanced solid tumors.
Gasparini G; Dal Fior S; Pozza F; Panizzoni GA; Favretto S; Von Hoff DD
Invest New Drugs; 1991 Aug; 9(3):245-52. PubMed ID: 1783524
[TBL] [Abstract][Full Text] [Related]
29. Recombinant leukocyte A interferon with doxorubicin. A phase I study in advanced solid neoplasms and implications for hepatocellular carcinoma.
Creagan ET; Long HJ; Frytak S; Moertel CG
Cancer; 1988 Jan; 61(1):19-22. PubMed ID: 2825959
[TBL] [Abstract][Full Text] [Related]
30. Intron A (interferon alfa-2b): clinical overview and future directions.
Spiegel RJ
Semin Oncol; 1986 Sep; 13(3 Suppl 2):89-101. PubMed ID: 3532338
[TBL] [Abstract][Full Text] [Related]
31. Human lymphoblastoid interferon (IFN-alpha-N1) plus doxorubicin, cyclophosphamide, and cisplatin in the treatment of advanced epithelial ovarian malignancies. A phase I-II study of the Gynecologic Oncology Group.
DiSaia PJ; Gillette P
Am J Clin Oncol; 1991 Feb; 14(1):71-4. PubMed ID: 1987744
[TBL] [Abstract][Full Text] [Related]
32. A randomized trial of low doses of alpha interferon in patients with breast cancer.
Laszlo J; Hood L; Cox E; Goodwin B
J Biol Response Mod; 1986 Jun; 5(3):206-10. PubMed ID: 3723137
[TBL] [Abstract][Full Text] [Related]
33. A phase II trial of recombinant leukocyte interferon plus doxorubicin in patients with hepatocellular carcinoma.
Feun LG; Savaraj N; Hung S; Reddy R; Jeffers L; Benedetto P; Livingstone AS; Ardalan B; Levi JU; Parker T
Am J Clin Oncol; 1994 Oct; 17(5):393-5. PubMed ID: 8092109
[TBL] [Abstract][Full Text] [Related]
34. Phase I study of recombinant leukocyte A interferon (IFN-alpha 2A, Roferon-A) with doxorubicin in advanced malignant disease.
Creagan ET; Frytak S; Long HJ; Kvols LK
Cancer; 1989 Sep; 64(5):1034-7. PubMed ID: 2474365
[TBL] [Abstract][Full Text] [Related]
35. Phase I trial of combinations of recombinant interferons beta(ser) and gamma in patients with advanced malignancy.
Schiller JH; Storer B; Willson JK; Borden EC
Cancer Treat Rep; 1987 Oct; 71(10):945-52. PubMed ID: 3115570
[TBL] [Abstract][Full Text] [Related]
36. A phase I clinical trial of recombinant DNA gamma interferon.
Brown TD; Koeller J; Beougher K; Golando J; Bonnem EM; Spiegel RJ; Von Hoff DD
J Clin Oncol; 1987 May; 5(5):790-8. PubMed ID: 3106584
[TBL] [Abstract][Full Text] [Related]
37. Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
Smith DB; Scarffe JH; Wagstaff J; Johnston RJ
Cancer Treat Rep; 1987 Dec; 71(12):1265-6. PubMed ID: 3690534
[TBL] [Abstract][Full Text] [Related]
38. Phase I study of a combination of recombinant interferon-alpha and recombinant interferon-gamma in cancer patients.
Kurzrock R; Rosenblum MG; Quesada JR; Sherwin SA; Itri LM; Gutterman JU
J Clin Oncol; 1986 Nov; 4(11):1677-83. PubMed ID: 3095504
[TBL] [Abstract][Full Text] [Related]
39. Phase II study of recombinant alfa-2a interferon in patients with advanced bone sarcomas.
Edmonson JH; Long HJ; Frytak S; Smithson WA; Itri LM
Cancer Treat Rep; 1987; 71(7-8):747-8. PubMed ID: 3038315
[TBL] [Abstract][Full Text] [Related]
40. Combined interferon alfa and doxorubicin in the treatment of advanced cervical cancer.
Welander CE; Homesley HD; Barrett RJ
Am J Obstet Gynecol; 1991 Aug; 165(2):284-90; discussion 290-1. PubMed ID: 1872328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
